secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0001567264-25-000071
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics raises $6.6M via ATM stock sales; cash runway extended to H2 2026
--------------------------------------------------------------------------------

- Gross proceeds of $6.6M ($6.3M net) from sale of 19,868,658 shares at avg $0.3323/share in July 2025.
- Shares outstanding post-ATM: 46,035,081 as of July 31, 2025.
- Average price per share >10% higher than June 2025 public offering, reducing dilution cost.
- Proceeds extend cash runway into second half of 2026 to advance clinical trials.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726425000071/0001567264-25-000071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726425000071/intensity-20250804.htm
  HTML page:      https://secwatch.observer/filing/0001567264-25-000071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer